RESECTABLE NON-SMALL CELL LUNG CANCER
Clinical trials for RESECTABLE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost lung cancer surgery success
Disease control OngoingThis study tests whether adding an experimental drug (fianlimab) to standard immunotherapy (cemiplimab) and chemotherapy helps people with early-stage lung cancer that can be removed by surgery. About 195 participants will receive the drug combination before and after surgery. Th…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Promising lung cancer drug combo trial pulled before starting
Disease control TerminatedThis study was designed to test the safety and effectiveness of giving the targeted drug adagrasib, alone or with the immunotherapy nivolumab, before surgery to people with a specific type of lung cancer (KRAS G12C mutation). The goal was to see if these drugs could shrink or eli…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New drug combo shows promise in shrinking lung tumors before surgery
Disease control OngoingThis study tests a new drug called AK112, given alone or with chemotherapy, before and after surgery for people with early-stage non-small cell lung cancer that can be removed. The goal is to see if the drug helps shrink tumors and improve outcomes. About 90 adults aged 18-75 wit…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 11, 2026 20:38 UTC